RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

On that note-the market didn't take any hints from the rNAI transactions done this past 12 months- Like Merck and Roche are bozos-I am not aware aside from the anti-body space where there is MEDX( PDLI patents expire in 6 years) and some newer tech you see investment into, CRXL, VICL( long shot?) maybe Regeneron with it's trap technology-- of any better platform... than Cortex's-and the valuation plus the AMEX situation keeps big money from really being a bid. It is a fat pitch, but may require more patience-where all of us are wearing thin